Table 1 Clinicopathological factors and MLK7-AS1 expression in ovarian cancer patients
Characteristics | Â | Total number | MLK7-AS1 expression | P-value | |||
|---|---|---|---|---|---|---|---|
High | Low | ||||||
n | % | n | % | ||||
Age | < 50 | 24 | 12 | 50 | 12 | 50 | 0.224 |
≥50 | 21 | 10 | 47.6 | 11 | 52.4 | ||
CA199 | <  40 | 22 | 13 | 59.1 | 9 | 40.9 | 0.312 |
≥40 | 23 | 10 | 43.5 | 13 | 56.5 | ||
Differentiation | Well | 16 | 6 | 37.5 | 10 | 62.5 | 0.058 |
Moderate | 17 | 9 | 52.9 | 8 | 47.1 | ||
Poor | 12 | 5 | 41.7 | 7 | 58.3 | ||
Menopause | Pre- | 20 | 8 | 40 | 12 | 60 | 0.145* |
Post- | 25 | 13 | 52 | 12 | 48 | ||
Depth of invasion | T1-T3 | 18 | 3 | 16.7 | 15 | 83.3 | 0.005* |
T4 | 27 | 17 | 63 | 10 | 37 | ||
Lymph node metastasis | Absent (N0) | 16 | 5 | 31.2 | 11 | 68.8 | < 0.001* |
Present (N1-N3) | 29 | 19 | 65.5 | 10 | 34.5 | ||
Distant metastasis | Absent (M0) | 15 | 2 | 13.3 | 13 | 86.7 | 0.023* |
Present (M1) | 30 | 24 | 80 | 6 | 20 | ||
TNM stage | I-II | 16 | 4 | 25 | 12 | 75 | < 0.001* |
III-IV | 29 | 24 | 82.8 | 5 | 17.2 | ||